These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 16941154)

  • 1. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
    Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
    Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
    Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
    Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
    Teshiba R; Kawano S; Wang LL; He L; Naranjo A; London WB; Seeger RC; Gastier-Foster JM; Look AT; Hogarty MD; Cohn SL; Maris JM; Park JR; Shimada H
    Pediatr Dev Pathol; 2014; 17(6):441-9. PubMed ID: 25207821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma.
    Altungoz O; Aygun N; Tumer S; Ozer E; Olgun N; Sakizli M
    Cancer Genet Cytogenet; 2007 Jan; 172(2):113-9. PubMed ID: 17213019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The International Neuroblastoma Pathology Classification (the Shimada system).
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
    Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups.
    Ambros IM; Hata J; Joshi VV; Roald B; Dehner LP; Tüchler H; Pötschger U; Shimada H
    Cancer; 2002 Mar; 94(5):1574-83. PubMed ID: 11920516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
    Kobayashi C; Monforte-Munoz HL; Gerbing RB; Stram DO; Matthay KK; Lukens JN; Seeger RC; Shimada H
    Cancer; 2005 Jan; 103(1):174-80. PubMed ID: 15549714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
    J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.
    Defferrari R; Mazzocco K; Ambros IM; Ambros PF; Bedwell C; Beiske K; Bénard J; Berbegall AP; Bown N; Combaret V; Couturier J; Erminio G; Gambini C; Garaventa A; Gross N; Haupt R; Kohler J; Jeison M; Lunec J; Marques B; Martinsson T; Noguera R; Parodi S; Schleiermacher G; Tweddle DA; Valent A; Van Roy N; Vicha A; Villamon E; Tonini GP
    Br J Cancer; 2015 Jan; 112(2):290-5. PubMed ID: 25356804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
    Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
    Sokol E; Desai AV; Applebaum MA; Valteau-Couanet D; Park JR; Pearson ADJ; Schleiermacher G; Irwin MS; Hogarty M; Naranjo A; Volchenboum S; Cohn SL; London WB
    J Clin Oncol; 2020 Jun; 38(17):1906-1918. PubMed ID: 32315273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
    Sano H; Bonadio J; Gerbing RB; London WB; Matthay KK; Lukens JN; Shimada H
    Eur J Cancer; 2006 May; 42(8):1113-9. PubMed ID: 16624549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
    Navarro S; Amann G; Beiske K; Cullinane CJ; d'Amore ES; Gambini C; Mosseri V; De Bernardi B; Michon J; Peuchmaur M;
    J Clin Oncol; 2006 Feb; 24(4):695-9. PubMed ID: 16446343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
    Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
    Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral neuroblastic tumors: anatomo pathological classification].
    Peuchmaur M
    Ann Pathol; 2004 Dec; 24(6):556-67. PubMed ID: 15785402
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Bhardwaj N; Rohilla M; Trehan A; Bansal D; Kakkar N; Srinivasan R
    J Clin Pathol; 2023 Sep; 76(9):599-605. PubMed ID: 35414524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic features of peripheral neuroblastic tumors].
    Yang BF; Fu LB; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
    Peuchmaur M; d'Amore ES; Joshi VV; Hata J; Roald B; Dehner LP; Gerbing RB; Stram DO; Lukens JN; Matthay KK; Shimada H
    Cancer; 2003 Nov; 98(10):2274-81. PubMed ID: 14601099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.